Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.
Criscitiello C, Disalvatore D, De Laurentiis M, Gelao L, Fumagalli L, Locatelli M, Bagnardi V, Rotmensz N, Esposito A, Minchella I, De Placido S, Santangelo M, Viale G, Goldhirsch A, Curigliano G. Criscitiello C, et al. Among authors: de placido s, de laurentiis m. Breast. 2014 Feb;23(1):69-75. doi: 10.1016/j.breast.2013.11.007. Epub 2013 Dec 4. Breast. 2014. PMID: 24314620
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
Di Lorenzo G, Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, D'Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F. Di Lorenzo G, et al. Among authors: de rosa g, de placido s, de laurentiis m. Clin Cancer Res. 2002 Nov;8(11):3438-44. Clin Cancer Res. 2002. PMID: 12429632
A novel neural network-based survival analysis model.
Eleuteri A, Tagliaferri R, Milano L, De Placido S, De Laurentiis M. Eleuteri A, et al. Among authors: de placido s, de laurentiis m. Neural Netw. 2003 Jun-Jul;16(5-6):855-64. doi: 10.1016/S0893-6080(03)00098-4. Neural Netw. 2003. PMID: 12850044
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
De Laurentiis M, Arpino G, Massarelli E, Ruggiero A, Carlomagno C, Ciardiello F, Tortora G, D'Agostino D, Caputo F, Cancello G, Montagna E, Malorni L, Zinno L, Lauria R, Bianco AR, De Placido S. De Laurentiis M, et al. Among authors: de placido s. Clin Cancer Res. 2005 Jul 1;11(13):4741-8. doi: 10.1158/1078-0432.CCR-04-2569. Clin Cancer Res. 2005. PMID: 16000569 Free article.
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trial.
Di Lorenzo G, Autorino R, De Laurentiis M, Forestieri V, Romano C, Prudente A, Giugliano F, Imbimbo C, Mirone V, De Placido S. Di Lorenzo G, et al. Among authors: de placido s, de laurentiis m. Cancer Biol Ther. 2007 Mar;6(3):313-7. doi: 10.4161/cbt.6.3.3664. Epub 2007 Mar 6. Cancer Biol Ther. 2007. PMID: 17327701 Clinical Trial.
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
Di Lorenzo G, Autorino R, Perdonà S, De Laurentiis M, D'Armiento M, Cancello G, Mirone V, Imbimbo C, Longo N, Altieri V, Tortora G, Figg WD, De Placido S. Di Lorenzo G, et al. Among authors: de placido s, de laurentiis m. Eur Urol. 2007 Oct;52(4):1020-7. doi: 10.1016/j.eururo.2007.02.060. Epub 2007 Mar 7. Eur Urol. 2007. PMID: 17360103 Clinical Trial.
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.
De Laurentiis M, Cancello G, D'Agostino D, Giuliano M, Giordano A, Montagna E, Lauria R, Forestieri V, Esposito A, Silvestro L, Pennacchio R, Criscitiello C, Montanino A, Limite G, Bianco AR, De Placido S. De Laurentiis M, et al. Among authors: de placido s. J Clin Oncol. 2008 Jan 1;26(1):44-53. doi: 10.1200/JCO.2007.11.3787. J Clin Oncol. 2008. PMID: 18165639
394 results